Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Albuterol | 4 | 2006 | 26 | 0.780 |
Why?
|
Bronchodilator Agents | 4 | 2006 | 43 | 0.760 |
Why?
|
Respiration, Artificial | 5 | 2006 | 190 | 0.590 |
Why?
|
Helium | 2 | 2006 | 9 | 0.450 |
Why?
|
Oxygen | 3 | 2006 | 386 | 0.400 |
Why?
|
Lung | 3 | 2006 | 849 | 0.330 |
Why?
|
Metered Dose Inhalers | 1 | 2006 | 4 | 0.280 |
Why?
|
Drug Delivery Systems | 2 | 1999 | 236 | 0.260 |
Why?
|
Status Epilepticus | 1 | 2004 | 74 | 0.230 |
Why?
|
Intensive Care Units, Pediatric | 6 | 2010 | 101 | 0.220 |
Why?
|
Nebulizers and Vaporizers | 2 | 2002 | 34 | 0.190 |
Why?
|
Heart Arrest | 2 | 1999 | 113 | 0.190 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2005 | 123 | 0.180 |
Why?
|
Life Support Care | 1 | 1999 | 12 | 0.170 |
Why?
|
Treatment Failure | 1 | 1999 | 216 | 0.160 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 1999 | 72 | 0.160 |
Why?
|
Infant | 8 | 2010 | 2891 | 0.150 |
Why?
|
Child | 10 | 2010 | 6405 | 0.150 |
Why?
|
Quinidine | 1 | 1997 | 15 | 0.150 |
Why?
|
Cardiopulmonary Bypass | 1 | 1999 | 250 | 0.140 |
Why?
|
Drowning | 1 | 1996 | 5 | 0.140 |
Why?
|
Near Drowning | 1 | 1996 | 3 | 0.140 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1997 | 98 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 1 | 1997 | 239 | 0.130 |
Why?
|
Child, Preschool | 8 | 2010 | 3187 | 0.120 |
Why?
|
Critical Illness | 2 | 2010 | 191 | 0.100 |
Why?
|
Asthma | 1 | 1996 | 345 | 0.100 |
Why?
|
Ventilator Weaning | 2 | 2002 | 27 | 0.100 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1991 | 153 | 0.090 |
Why?
|
Jugular Veins | 1 | 2010 | 37 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 89 | 0.090 |
Why?
|
Respiratory Mechanics | 2 | 2002 | 33 | 0.090 |
Why?
|
Prospective Studies | 4 | 2010 | 3705 | 0.080 |
Why?
|
Hemodynamics | 4 | 2004 | 705 | 0.080 |
Why?
|
Humans | 17 | 2010 | 68618 | 0.070 |
Why?
|
Aerosols | 1 | 2006 | 42 | 0.070 |
Why?
|
In Vitro Techniques | 1 | 2006 | 765 | 0.060 |
Why?
|
GABA Modulators | 1 | 2004 | 26 | 0.060 |
Why?
|
Spinal Puncture | 1 | 2004 | 38 | 0.060 |
Why?
|
Myocardium | 1 | 1991 | 1204 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2005 | 76 | 0.060 |
Why?
|
Radiography | 1 | 2004 | 572 | 0.050 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2004 | 138 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2004 | 223 | 0.050 |
Why?
|
Respiration Disorders | 1 | 2002 | 20 | 0.050 |
Why?
|
Norepinephrine | 3 | 1992 | 276 | 0.050 |
Why?
|
Catheterization, Peripheral | 1 | 2002 | 38 | 0.050 |
Why?
|
Total Quality Management | 1 | 2002 | 45 | 0.050 |
Why?
|
Heart Rate | 2 | 2002 | 568 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2002 | 260 | 0.050 |
Why?
|
Pediatrics | 1 | 2005 | 341 | 0.050 |
Why?
|
Time Factors | 3 | 2002 | 4655 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2001 | 172 | 0.050 |
Why?
|
Sickle Cell Trait | 1 | 2000 | 24 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2000 | 117 | 0.050 |
Why?
|
Pleural Effusion | 1 | 2000 | 74 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2004 | 450 | 0.040 |
Why?
|
Chest Pain | 1 | 2000 | 151 | 0.040 |
Why?
|
Models, Structural | 1 | 1999 | 22 | 0.040 |
Why?
|
Algorithms | 2 | 2002 | 1196 | 0.040 |
Why?
|
Fatal Outcome | 1 | 1999 | 164 | 0.040 |
Why?
|
Emergencies | 1 | 1999 | 107 | 0.040 |
Why?
|
Sheep | 4 | 1991 | 128 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 1999 | 187 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2002 | 1738 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1999 | 381 | 0.040 |
Why?
|
Blood Pressure | 2 | 2002 | 1451 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2010 | 2455 | 0.040 |
Why?
|
Bezoars | 1 | 1997 | 3 | 0.040 |
Why?
|
Adolescent | 4 | 2010 | 8912 | 0.040 |
Why?
|
Stomach | 1 | 1997 | 80 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 1997 | 120 | 0.040 |
Why?
|
Coma | 1 | 1996 | 17 | 0.030 |
Why?
|
Hypotension | 1 | 1997 | 74 | 0.030 |
Why?
|
Drug Overdose | 1 | 1997 | 67 | 0.030 |
Why?
|
Cardiac Catheterization | 1 | 1999 | 419 | 0.030 |
Why?
|
Cytokines | 1 | 2000 | 866 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1996 | 107 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1996 | 137 | 0.030 |
Why?
|
Animals, Newborn | 3 | 1991 | 396 | 0.030 |
Why?
|
Forecasting | 1 | 1996 | 277 | 0.030 |
Why?
|
Epinephrine | 2 | 1992 | 103 | 0.030 |
Why?
|
Brain | 1 | 2004 | 2176 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 1996 | 1465 | 0.030 |
Why?
|
Dobutamine | 1 | 1992 | 25 | 0.030 |
Why?
|
South Carolina | 3 | 2005 | 2752 | 0.030 |
Why?
|
Drug Monitoring | 1 | 1992 | 107 | 0.020 |
Why?
|
Enkephalin, Methionine | 1 | 1991 | 20 | 0.020 |
Why?
|
Dopamine | 2 | 1992 | 474 | 0.020 |
Why?
|
Adrenal Glands | 1 | 1991 | 46 | 0.020 |
Why?
|
Male | 5 | 2005 | 37321 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1991 | 32 | 0.020 |
Why?
|
Catecholamines | 1 | 1991 | 73 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2010 | 46 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 1996 | 711 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1991 | 223 | 0.020 |
Why?
|
Benzazepines | 1 | 1991 | 104 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2010 | 7029 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1990 | 91 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1991 | 189 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 1989 | 5 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 1996 | 2550 | 0.020 |
Why?
|
Pulmonary Artery | 2 | 2004 | 323 | 0.020 |
Why?
|
Aging | 2 | 1991 | 911 | 0.020 |
Why?
|
Risk Factors | 1 | 1996 | 5731 | 0.020 |
Why?
|
Female | 4 | 2005 | 38074 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2004 | 41 | 0.020 |
Why?
|
Catheterization | 1 | 2005 | 209 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1996 | 7277 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 242 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 3259 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 714 | 0.010 |
Why?
|
Animals | 5 | 1991 | 20881 | 0.010 |
Why?
|
Palliative Care | 1 | 2004 | 271 | 0.010 |
Why?
|
Software Design | 1 | 2001 | 18 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 1056 | 0.010 |
Why?
|
Length of Stay | 1 | 2005 | 780 | 0.010 |
Why?
|
Metabolic Clearance Rate | 2 | 1992 | 48 | 0.010 |
Why?
|
Hospitals, University | 1 | 2001 | 169 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 306 | 0.010 |
Why?
|
Duffy Blood-Group System | 1 | 2000 | 2 | 0.010 |
Why?
|
Infusions, Intravenous | 2 | 1992 | 334 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2000 | 71 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2000 | 74 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 255 | 0.010 |
Why?
|
Regression Analysis | 1 | 2002 | 737 | 0.010 |
Why?
|
Hypoxia | 2 | 1991 | 169 | 0.010 |
Why?
|
Gestational Age | 2 | 1991 | 389 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 492 | 0.010 |
Why?
|
Patient Care Team | 1 | 2001 | 311 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 5717 | 0.010 |
Why?
|
Acute Disease | 1 | 2000 | 658 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1992 | 1745 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2000 | 1553 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2000 | 1664 | 0.010 |
Why?
|
Adult | 2 | 2002 | 21403 | 0.010 |
Why?
|
California | 1 | 1992 | 99 | 0.010 |
Why?
|
Cardiac Output | 1 | 1992 | 133 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1991 | 164 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 1992 | 114 | 0.010 |
Why?
|
Neural Crest | 1 | 1991 | 58 | 0.010 |
Why?
|
Tolazoline | 1 | 1991 | 2 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1991 | 27 | 0.010 |
Why?
|
Organ Specificity | 1 | 1991 | 167 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 1991 | 79 | 0.010 |
Why?
|
Rabbits | 1 | 1991 | 509 | 0.010 |
Why?
|
Body Weight | 1 | 1992 | 554 | 0.010 |
Why?
|
Birth Weight | 1 | 1990 | 186 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1992 | 384 | 0.010 |
Why?
|
Kinetics | 1 | 1991 | 1047 | 0.010 |
Why?
|
Critical Care | 1 | 1990 | 263 | 0.000 |
Why?
|